Seminars in Oncology
Volume 36, Issue 4 , Pages 290-301 , August 2009

Gastrointestinal Stromal Tumors I: Pathology, Pathobiology, Primary Therapy, and Surgical Issues

  • Peter Reichardt

      Affiliations

    • Sarcoma Center Berlin-Brandenburg, HELIOS Klinikum Bad Saarow, Bad Saarow, Germany
    • These authors contributed equally to this work.
    • ,
  • Pancras C.W. Hogendoorn

      Affiliations

    • Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands
    • These authors contributed equally to this work.
    • ,
  • Elena Tamborini

      Affiliations

    • Laboratory of Experimental Molecular Pathology, IRCCS Foundation, Istituto Nazionale Tumori, Milan, Italy
    • These authors contributed equally to this work.
    • ,
  • Massimo Loda

      Affiliations

    • Dana-Farber Cancer Institute, Boston, MA
    • These authors contributed equally to this work.
    • ,
  • Alessandro Gronchi

      Affiliations

    • Department of Surgery, Istituto Nazionale Tumori, Milan, Italy
    • These authors contributed equally to this work.
    • ,
  • Andrés Poveda

      Affiliations

    • Instituto Valenciano de Oncología, Valencia, Spain
    • These authors contributed equally to this work.
    • ,
  • Patrick Schöffski

      Affiliations

    • University Hospitals Leuven, Department of General Medical Oncology and Laboratory of Experimental Oncology Leuven Cancer Institute, Catholic University Leuven, Leuven, Belgium
    • These authors contributed equally to this work.
    • Corresponding Author InformationAddress correspondence to Patrick Schöffski, MD, MPH, University Hospitals Leuven, Department of General Medical Oncology and Laboratory of Experimental Oncology, Leuven Cancer Institute, Catholic University Leuven, Herestraat 49, B-3000 Leuven, Belgium

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

Disclosures P. Reichardt: Pfizer, Novartis (honoraria); research funding (Novartis)A. Gronchi: Novartis (honoraria)P. Schöffski: Pfizer (honoraria and research funding); Novartis (honoraria and research funding)Other authors: no significant relationships

PII: S0093-7754(09)00102-X

doi: 10.1053/j.seminoncol.2009.06.002

Seminars in Oncology
Volume 36, Issue 4 , Pages 290-301 , August 2009

Article Tools

* Image Usage & Resolution